SCHEMBL3851329

SCHEMBL3851329

N#Cc1ccc(-c2n[nH]cc2I)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.40
SCN5A Q14524 1/20 0.40
SCN9A Q15858 1/20 0.40
NOTUM Q6P988 2/20 0.39
MAPK13 O15264 2/20 0.38
MAPK12 P53778 2/20 0.38
MAPK11 Q15759 2/20 0.38
MAPK14 Q16539 2/20 0.38
RAF1 P04049 1/20 0.38
MMP3 P08254 1/20 0.38
ALOX5 P09917 1/20 0.38
GCGR P47871 1/20 0.38
HSP90AB1 P08238 2/20 0.37
CHEK1 O14757 1/20 0.36
TDO2 P48775 1/20 0.36
KDM1A O60341 2/20 0.36
CYP11B2 P19099 1/20 0.36
KIF11 P52732 2/20 0.35
CXCR2 P25025 1/20 0.35
LRRK2 Q5S007 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3847777 0.80 IDO1 (0.48) NOTUMTDO2LRRK2
SCHEMBL27844934 0.79 ERBB2 (0.41) TRPA1SCN5ASCN9ANOTUMMAPK13
SCHEMBL4282428 0.76 MAOB (0.46) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL18757602 0.76 PDPK1 (0.42) HSP90AB1
SCHEMBL16847971 0.76 ERBB2 (0.41) NOTUMMAPK13MAPK12MAPK11MAPK14
SCHEMBL11623164 0.75 ALOX15 (0.48) ERBB2
SCHEMBL13592411 0.75 NOTUM (0.40) TRPA1SCN5ASCN9ANOTUMMAPK13
SCHEMBL20564207 0.73 LMNA (0.40) NOTUMMAPK13MAPK12MAPK11MAPK14
SCHEMBL20262084 0.73 NISCH (0.39) MAPK13MAPK12MAPK11MAPK14ALOX5
SCHEMBL30239600 0.72 MAPK14 (0.49) MAPK13MAPK12MAPK11MAPK14RAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed